Q13443 (ADAM9_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 138.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Disintegrin and metalloproteinase domain-containing protein 9 Short name=ADAM 9 EC=3.4.24.- Alternative name(s): Cellular disintegrin-related protein Meltrin-gamma Metalloprotease/disintegrin/cysteine-rich protein 9 Myeloma cell metalloproteinase | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 819 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Probable zinc protease. May mediate cell-cell or cell-matrix interactions. Isoform 2 displays alpha-secretase activity for APP. Ref.3 |
| Cofactor | Binds 1 zinc ion per subunit Probable. |
| Subunit structure | Interacts with SH3GL2 and SNX9 through its cytoplasmic tail. Ref.9 |
| Subcellular location | Isoform 1: Cell membrane; Single-pass type I membrane protein Ref.3. |
| Tissue specificity | Widely expressed. Expressed in chondrocytes. Isoform 2 is highly expressed in liver and heart. Ref.1 Ref.3 Ref.4 Ref.8 |
| Involvement in disease | Cone-rod dystrophy 9 (CORD9) [MIM:612775]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. |
| Sequence similarities | Contains 1 disintegrin domain. Contains 1 EGF-like domain. Contains 1 peptidase M12B domain. |
| Caution | Has sometimes been referred to as ADAM-12. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| MAD2L2 | Q9UI95 | 3 | EBI-77903,EBI-77889 | |
| PACSIN3 | Q9UKS6 | 2 | EBI-77903,EBI-77926 | |
| SH3GL2 | Q99962 | 2 | EBI-77903,EBI-77938 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13443-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q13443-2) The sequence of this isoform differs from the canonical sequence as follows: 655-655: V → K 656-819: Missing. | ||||||
| Note: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Potential | ||||||||||||||||||||||||||||||||||
| Chain | 29 – 819 | 791 | Disintegrin and metalloproteinase domain-containing protein 9 | PRO_0000029062 | |||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||
| Topological domain | 29 – 697 | 669 | Extracellular Potential | ||||||||||||||||||||||||||||||||||
| Transmembrane | 698 – 718 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||
| Topological domain | 719 – 819 | 101 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||
| Domain | 212 – 406 | 195 | Peptidase M12B | ||||||||||||||||||||||||||||||||||
| Domain | 414 – 501 | 88 | Disintegrin | ||||||||||||||||||||||||||||||||||
| Domain | 644 – 698 | 55 | EGF-like | ||||||||||||||||||||||||||||||||||
| Compositional bias | 505 – 634 | 130 | Cys-rich | ||||||||||||||||||||||||||||||||||
| Compositional bias | 790 – 795 | 6 | Poly-Pro | ||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||
| Active site | 348 | 1 | By similarity | ||||||||||||||||||||||||||||||||||
| Metal binding | 347 | 1 | Zinc; catalytic By similarity | ||||||||||||||||||||||||||||||||||
| Metal binding | 351 | 1 | Zinc; catalytic By similarity | ||||||||||||||||||||||||||||||||||
| Metal binding | 357 | 1 | Zinc; catalytic By similarity | ||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||
| Glycosylation | 125 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Glycosylation | 144 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Glycosylation | 154 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Glycosylation | 231 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Glycosylation | 381 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Glycosylation | 487 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||
| Disulfide bond | 322 ↔ 401 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 363 ↔ 385 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 365 ↔ 370 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 473 ↔ 493 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 644 ↔ 656 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 650 ↔ 662 | By similarity | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 664 ↔ 673 | By similarity | |||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||
| Alternative sequence | 655 | 1 | V → K in isoform 2. | VSP_011057 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 656 – 819 | 164 | Missing in isoform 2. | VSP_011058 | |||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 1 – 118 | 118 | Missing no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 117 | 1 | R → Q in BAA03499. Ref.4 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 119 – 135 | 17 | YVEGV…SDCFG → MWREFIIHPLLLATVLD no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 154 | 1 | N → M no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 566 | 1 | G → GLSLKFHAPFLSTMLQEAVR QTGTYLGGSVCCMKSDCRIV TLVK no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 713 – 735 | 23 | AIFIF…KRSQT → DYFYLHQEGSTVEKLLQKEE ITN no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 736 – 819 | 84 | Missing no nucleotide entry Ref.2 | ||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||
| Beta strand | 212 – 220 | 9 | |||||||||||||||||||||||||||||||||||
| Helix | 222 – 227 | 6 | |||||||||||||||||||||||||||||||||||
| Turn | 228 – 230 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 232 – 250 | 19 | |||||||||||||||||||||||||||||||||||
| Helix | 251 – 253 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 255 – 264 | 10 | |||||||||||||||||||||||||||||||||||
| Helix | 277 – 290 | 14 | |||||||||||||||||||||||||||||||||||
| Turn | 291 – 295 | 5 | |||||||||||||||||||||||||||||||||||
| Beta strand | 299 – 305 | 7 | |||||||||||||||||||||||||||||||||||
| Beta strand | 311 – 316 | 6 | |||||||||||||||||||||||||||||||||||
| Beta strand | 327 – 331 | 5 | |||||||||||||||||||||||||||||||||||
| Turn | 337 – 339 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 340 – 352 | 13 | |||||||||||||||||||||||||||||||||||
| Beta strand | 369 – 374 | 6 | |||||||||||||||||||||||||||||||||||
| Helix | 384 – 397 | 14 | |||||||||||||||||||||||||||||||||||
| Helix | 400 – 402 | 3 | |||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains." Weskamp G., Kraetzschmar J., Reid M.S., Blobel C.P. J. Cell Biol. 132:717-726(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Mammary carcinoma. |
| [2] | "Cloning of a novel membrane-linked metalloproteinase from human myeloma cells." McKie N., Dallas D.J., Edwards T., Apperley J.F., Russell R.G.G., Croucher P.I. Biochem. J. 318:459-462(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Placenta. |
| [3] | "A secreted form of human ADAM9 has an alpha-secretase activity for APP." Hotoda N., Koike H., Sasagawa N., Ishiura S. Biochem. Biophys. Res. Commun. 293:800-805(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [4] | "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1." Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S., Nagase T., Seki N., Ishikawa K., Tabata S. DNA Res. 1:27-35(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Bone marrow. |
| [5] | Ohara O., Nagase T., Kikuno R., Nomura N. Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Lung. |
| [8] | "Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes." McKie N., Edwards T., Dallas D.J., Houghton A., Stringer B., Graham R., Russell G., Croucher P.I. Biochem. Biophys. Res. Commun. 230:335-339(1997) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1." Howard L., Nelson K.K., Maciewicz R.A., Blobel C.P. J. Biol. Chem. 274:31693-31699(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SH3GL2 AND SNX9. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [11] | "Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice." Parry D.A., Toomes C., Bida L., Danciger M., Towns K.V., McKibbin M., Jacobson S.G., Logan C.V., Ali M., Bond J., Chance R., Swendeman S., Daniele L.L., Springell K., Adams M., Johnson C.A., Booth A.P., Jafri H. Inglehearn C.F.Am. J. Hum. Genet. 84:683-691(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN CORD9. |
| [12] | "Exploring the substrate affinities of MMP-3, ADAM-9 and ADAM-10 using molecular modelling and dynamics simulations." Manzetti S., McCulloch D.R., Herington A.C. Submitted (JUN-2002) to the PDB data bank Cited for: 3D-STRUCTURE MODELING OF 208-404. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U41766 mRNA. Translation: AAC50403.1. AF495383 mRNA. Translation: AAM49575.1. D14665 mRNA. Translation: BAA03499.2. CH471080 Genomic DNA. Translation: EAW63284.1. BC143923 mRNA. Translation: AAI43924.1. | ||||||||||||
| IPI | IPI00440932. IPI00440933. | ||||||||||||
| PIR | JC7850. S71949. | ||||||||||||
| RefSeq | NP_003807.1. NM_003816.2. | ||||||||||||
| UniGene | Hs.591852. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q13443. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q13443. 3 interactions. | ||||||||||||
| MINT | MINT-108373. | ||||||||||||
| STRING | 9606.ENSP00000305538. | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | M12.209. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q13443. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 24211441. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q13443. | ||||||||||||
| PRIDE | Q13443. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000379917; ENSP00000369249; ENSG00000168615. ENST00000487273; ENSP00000419446; ENSG00000168615. | ||||||||||||
| GeneID | 8754. | ||||||||||||
| KEGG | hsa:8754. | ||||||||||||
| UCSC | uc003xmr.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 8754. | ||||||||||||
| GeneCards | GC08P038871. | ||||||||||||
| HGNC | HGNC:216. ADAM9. | ||||||||||||
| HPA | HPA004000. | ||||||||||||
| MIM | 602713. gene. 612775. phenotype. | ||||||||||||
| neXtProt | NX_Q13443. | ||||||||||||
| Orphanet | 1872. Cone rod dystrophy. | ||||||||||||
| PharmGKB | PA24534. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG294463. | ||||||||||||
| HOGENOM | HOG000230883. | ||||||||||||
| HOVERGEN | HBG006978. | ||||||||||||
| InParanoid | Q13443. | ||||||||||||
| KO | K06834. | ||||||||||||
| OMA | HDDGRDC. | ||||||||||||
| PhylomeDB | Q13443. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_118779. Extracellular matrix organization. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q13443. | ||||||||||||
| Bgee | Q13443. | ||||||||||||
| CleanEx | HS_ADAM9. | ||||||||||||
| Genevestigator | Q13443. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 3.40.390.10. 1 hit. 4.10.70.10. 1 hit. | ||||||||||||
| InterPro | IPR006586. ADAM_Cys-rich. IPR001762. Blood-coag_inhib_Disintegrin. IPR018358. Disintegrin_CS. IPR000742. EG-like_dom. IPR013032. EGF-like_CS. IPR024079. MetalloPept_cat_dom. IPR001590. Peptidase_M12B. IPR002870. Peptidase_M12B_N. [Graphical view] | ||||||||||||
| Pfam | PF08516. ADAM_CR. 1 hit. PF00200. Disintegrin. 1 hit. PF01562. Pep_M12B_propep. 1 hit. PF01421. Reprolysin. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00608. ACR. 1 hit. SM00050. DISIN. 1 hit. SM00181. EGF. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF57552. Disintegrin. 1 hit. | ||||||||||||
| PROSITE | PS50215. ADAM_MEPRO. 1 hit. PS00427. DISINTEGRIN_1. 1 hit. PS50214. DISINTEGRIN_2. 1 hit. PS00022. EGF_1. False negative. PS01186. EGF_2. 1 hit. PS50026. EGF_3. 1 hit. PS00142. ZINC_PROTEASE. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q13443. | ||||||||||||
| ChEMBL | CHEMBL5982. | ||||||||||||
| GenomeRNAi | 8754. | ||||||||||||
| NextBio | 32845. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | ADAM9_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13443 Secondary accession number(s): B7ZLN7, Q10718, Q8NFM6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
